Terms: = Ovarian cancer AND CEACAM5, CEA
732 results:
1. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting ovarian cancer Compared to Pathological Findings.
Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
[TBL] [Abstract] [Full Text] [Related]
2. Mucin-producing tumors of the ovary--preoperative differentiation between metastatic ovarian mucinous carcinoma and primary mucinous malignant tumors.
Cai SQ; Wu MR; Ma XL; Lu JJ; Qiang JW; Guan YY; Zeng MS; Zhou JJ
J Ovarian Res; 2024 Mar; 17(1):59. PubMed ID: 38481236
[TBL] [Abstract] [Full Text] [Related]
3. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
Shan D; Cheng S; Ma Y; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative serum CA125 level is a good prognostic predictor in patients with intrahepatic cholangiocarcinoma after hepatectomy: A single-center retrospective study.
Meng J; Weng J; Wu J; Mao H; Huang P; Chen S; Liu L
Medicine (Baltimore); 2023 Sep; 102(36):e34839. PubMed ID: 37682202
[TBL] [Abstract] [Full Text] [Related]
5. MOF-Based Biosensors for the Detection of Carcinoembryonic Antigen: A Concise Review.
Ibrahim MR; Greish YE
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630221
[TBL] [Abstract] [Full Text] [Related]
6. Mucinous cystadenocarcinoma of the ovary in a 14-year-old girl: a case report and literature review.
Li Q; Zou C; Xu Y; Liu S; Yan T
BMC Womens Health; 2023 Jul; 23(1):382. PubMed ID: 37479970
[TBL] [Abstract] [Full Text] [Related]
7. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
[TBL] [Abstract] [Full Text] [Related]
8. ovarian Clear Cell Carcinoma and Rectal Adenocarcinoma Detected by Tubo-ovarian Abscess: A Case Report.
Matsuno M; Kurita T; Shibahara M; Aoyama Y; Hoshino K; Nishimura K; Harada H; Ueda T; Matsuura Y; Yoshino K
J UOEH; 2023; 45(2):117-122. PubMed ID: 37258243
[TBL] [Abstract] [Full Text] [Related]
9. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
[No Abstract] [Full Text] [Related]
10. [A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin].
Ishii M; Yamamoto Y; Yoshimura A; Hayashi T; Kawamura N; Nagahara A; Nakai Y; Nakayama M; Nishimura K
Hinyokika Kiyo; 2023 Apr; 69(4):107-112. PubMed ID: 37183041
[TBL] [Abstract] [Full Text] [Related]
11. Diffusion-weighted magnetic resonance sequence and CA125/cea ratio can be used as add-on tools to ultrasound for the differentiation of ovarian from non-ovarian pelvic masses.
Nunes Pereira P; Françoise Derchain S; Yoshida A; Hoelz de Oliveira Barros R; Menezes Jales R; Sarian LO
PLoS One; 2023; 18(3):e0283212. PubMed ID: 36928256
[TBL] [Abstract] [Full Text] [Related]
12. ovarian strumal carcinoid: a case report.
Kanasugi M; Nishiyama H; Sanpei M; Asano S; Honda T
Fukushima J Med Sci; 2023 Apr; 69(1):51-55. PubMed ID: 36878591
[TBL] [Abstract] [Full Text] [Related]
13. A Multiple-Array SPRi Biosensor as a Tool for Detection of Gynecological-Oncological Diseases.
Szymanska B; Lukaszewski Z; Hermanowicz-Szamatowicz K; Gorodkiewicz E
Biosensors (Basel); 2023 Feb; 13(2):. PubMed ID: 36832045
[TBL] [Abstract] [Full Text] [Related]
14. ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutic Applications for Oncolytic Self-Replicating RNA Viruses.
Lundstrom K
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555262
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathologic Features and the Loss of ARID1A Expression in ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract] [Full Text] [Related]
17. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
18. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
19. Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors.
Kobayashi H; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kimura F
J Obstet Gynaecol Res; 2022 Sep; 48(9):2442-2451. PubMed ID: 35778814
[TBL] [Abstract] [Full Text] [Related]
20. Association between Rheumatoid Arthritis Disease Activity and Risk of ovarian Malignancy in Middle-Aged and Elderly Women.
Huang Z; Tan L; Ling Y; Huang F; Ma W
Biomed Res Int; 2022; 2022():1062703. PubMed ID: 35663045
[TBL] [Abstract] [Full Text] [Related]
[Next]
